Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$23.2 - $27.29 $270,929 - $318,692
-11,678 Reduced 13.16%
77,054 $1.89 Million
Q1 2023

May 08, 2023

BUY
$22.26 - $30.85 $1,157 - $1,604
52 Added 0.06%
88,732 $2.06 Million
Q4 2022

Feb 14, 2023

SELL
$19.96 - $28.22 $4,810 - $6,801
-241 Reduced 0.27%
88,680 $2.24 Million
Q3 2022

Nov 10, 2022

SELL
$18.26 - $31.1 $315,824 - $537,905
-17,296 Reduced 16.28%
88,921 $1.72 Million
Q2 2022

Aug 12, 2022

SELL
$19.08 - $26.7 $715,499 - $1 Million
-37,500 Reduced 26.09%
106,217 $2.71 Million
Q1 2022

May 04, 2022

BUY
$21.19 - $40.01 $986,903 - $1.86 Million
46,574 Added 47.94%
143,717 $3.7 Million
Q4 2021

Feb 14, 2022

BUY
$30.97 - $54.03 $3.01 Million - $5.25 Million
97,143 New
97,143 $4.07 Million
Q3 2021

Nov 08, 2021

SELL
$34.9 - $54.54 $310,470 - $485,187
-8,896 Closed
0 $0
Q2 2021

Aug 09, 2021

BUY
$38.75 - $51.0 $116 - $153
3 Added 0.03%
8,896 $420,000
Q1 2021

May 13, 2021

SELL
$26.34 - $83.07 $72,909 - $229,937
-2,768 Reduced 23.74%
8,893 $456,000
Q4 2020

Feb 09, 2021

SELL
$25.51 - $43.38 $409,001 - $695,511
-16,033 Reduced 57.89%
11,661 $311,000
Q3 2020

Nov 09, 2020

BUY
$28.28 - $53.6 $783,186 - $1.48 Million
27,694 New
27,694 $951,000

Others Institutions Holding VIR

About Vir Biotechnology, Inc.


  • Ticker VIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 132,638,000
  • Market Cap $982M
  • Description
  • Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...
More about VIR
Track This Portfolio

Track Clari Vest Asset Management LLC Portfolio

Follow Clari Vest Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clari Vest Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clari Vest Asset Management LLC with notifications on news.